When comparing the treated mice to the control group, researchers found that SARS-CoV2 was killed off in the former group’s lungs by 99.9 percent. “This suggests that our treatment substantially repressed the virus in the mice lungs to the point that we can’t grow infectious virus from these lungs,” said Professor Morris. In the paper, the researchers state that “despite several emerging vaccines, there remains no verifiable therapeutic targeted specifically to the [COVID-19] virus. Here we present a highly effective siRNA therapeutic against SARS-CoV-2 infection.”The implications of this research go far beyond COVID-19, though. “The SARS virus will be with us for eternity,” Professor Morris explained.